Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-14T10:20:53.050Z Has data issue: false hasContentIssue false

65 - Botulism

from Part IV - Current Topics

Published online by Cambridge University Press:  15 December 2009

David M. Stier
Affiliation:
Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Nikkita Patel
Affiliation:
Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Olivia Bruch
Affiliation:
Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Karen A. Holbrook
Affiliation:
Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION

Botulism is a disease caused by exposure to botulinum toxin produced from Clostridium species, mainly Clostridium botulinum. Clinical forms of the disease include foodborne, inhalational, wound, infant, adult intestinal toxemia, and iatrogenic. C. botulinum is a gram-positive, strictly anaerobic, spore-forming bacillus naturally found in soil and aquatic sediments. There are seven types of the toxin based on antigenic differences, labeled A through G. Types A, B, and E (and rarely, F) are pathogenic in humans. Types C, D, and E cause illness in other mammals, birds, and fish. Botulinum toxin lacks color, odor, and taste and is the most lethal toxin known. Death is caused by doses of less than 1 μg. Antibiotics have no activity against the toxin itself.

In response to unfavorable environmental conditions (changes in pH, temperature, and water or nutrient availability), C. botulinum bacteria “sporulate.” C. botulinum spores are hardy, resistant to desiccation, heat, ultraviolet (UV) light, and alcohols, and can survive boiling for up to 4 hours; however, they are readily killed by chlorine-based disinfectants. Once spores encounter more favorable conditions, such as are found in human tissues, they “germinate,” producing growing cells that are capable of reproducing and elaborating toxin.

The Working Group for Civilian Biodefense considers botulism to be a dangerous potential biological weapon because of the pathogen's “extreme potency and lethality; its ease of production, transport, and misuse; and the need for prolonged intensive care among affected persons.”

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Black, R E, Gunn, R A. Hypersensitivity reactions associated with botulinum antitoxin. Am J Med 1980:69:567–70.CrossRefGoogle Scholar
Centers for Disease Control (CDC). Botulism: diagnosis and laboratory guidance for clinicians. Retrieved October 6, 2006, from http://www.bt.cdc.gov/agent/Botulism/clinicians/diagnosis.asp.
Centers for Disease Control (CDC). Drug service: General information. Retrieved April 16, 2007, from http://www. cdc.gov/ncidod/srp/drugs/formulary.html#1a.
Chertow, D S, Tan, E T, Maslanka, S E, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 2006;296(20):2476–9.CrossRefGoogle ScholarPubMed
Chin, J. Control of communicable diseases manual (17th ed.). Washington, DC: American Public Health Association, 2000.Google Scholar
Franz, D R, Jahrling, P B, Friedlander, A M, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278(5):399–411.CrossRefGoogle ScholarPubMed
Horowitz, B Z. Botulinum toxin. Crit Care Clin 2005;21:825–39.CrossRefGoogle ScholarPubMed
Kongsaengdao, S, Samintarapanya, K, Rusmeechan, S, et al. An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 2006;43:1247–56.CrossRefGoogle ScholarPubMed
Middlebrook J L, Franz D R. Botulinum toxins. In: Sidell, F R, Takafuji, E T, Franz, D R, eds, Medical aspects of chemical and biological warfare (Textbook of military medicine, part I, vol 3). Washington, DC: Office of the Surgeon General, 1997:643–54.CrossRefGoogle Scholar
Nishiura, H. Incubation period as a clinical predictor of botulism: analysis of precious izushi-borne outbreaks in Hokkaido, Japan, from 1951 to 1965. Epidemiol Infect 2006;1–5.Google Scholar
Peck, M W. Clostridium botulinum and the safety of minimally heated, chilled foods: an emerging issue?J Appl Microbiol 2006;101:556–70.CrossRefGoogle ScholarPubMed
Shapiro, R L, Hatheway, C, Becher, J, et al. Botulism surveillance and emergency response: a public health strategy for a global challenge. JAMA 1997;278(5):433–5.CrossRefGoogle ScholarPubMed
Sobel, J. Botulism. Clin Infect Dis 2005;41:1167–73.CrossRefGoogle ScholarPubMed
Sobel, J, Tucker, N, McLaughlin, J, et al. Foodborne botulism in the United States, 1990–2000. Emerg Infect Dis 2004 Sep;10(9):1606–11.CrossRefGoogle Scholar
Arnon, S S, Schechter, R, Inglesby, T V, et al. Botulinum toxin as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2001;285(8):1059–70.CrossRefGoogle Scholar
Bleck T P. Botulinum toxin as a biological weapon. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar
Bleck T P. Clostridium botulinum. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar
Center for Infectious Disease Research and Policy (CIDRAP). Botulism: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, and treatment. Retrieved March 5, 2007, from http://www.cidrap.umn.edu/cidrap/content/bt/botulism.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Botulism
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.066
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Botulism
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.066
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Botulism
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.066
Available formats
×